Eagle Bay Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-337
| Closed | -$566 | – | 663 |
|
|
2024
Q4 | $566 | Hold |
337
| – | – | ﹤0.01% | 958 |
|
|
2024
Q3 | $960 | Hold |
337
| – | – | ﹤0.01% | 1292 |
|
|
2024
Q2 | $789 | Hold |
337
| – | – | ﹤0.01% | 945 |
|
|
2024
Q1 | $991 | Hold |
337
| – | – | ﹤0.01% | 928 |
|
|
2023
Q4 | $1.01K | Hold |
337
| – | – | ﹤0.01% | 783 |
|
|
2023
Q3 | $1.07K | Hold |
337
| – | – | ﹤0.01% | 800 |
|
|
2023
Q2 | $1.3K | Hold |
337
| – | – | ﹤0.01% | 789 |
|
|
2023
Q1 | $933 | Hold |
337
| – | – | ﹤0.01% | 818 |
|
|
2022
Q4 | $607 | Hold |
337
| – | – | ﹤0.01% | 856 |
|
|
2022
Q3 | $1K | Hold |
337
| – | – | ﹤0.01% | 842 |
|
|
2022
Q2 | $907 | Buy |
+337
| New | +$907 | ﹤0.01% | 865 |
|
|
2022
Q1 | – | Sell |
-337
| Closed | -$2K | – | 707 |
|
|
2021
Q4 | $2K | Hold |
337
| – | – | ﹤0.01% | 892 |
|
|
2021
Q3 | $2K | Buy |
+337
| New | +$2K | ﹤0.01% | 921 |
|